Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXKF9D
|
||||
| Drug Name |
3-isopropyl-N-(3-(3-(4-(methylamino)-1,3,5-triazin-2-yl)pyridin-2-yloxy)phenyl)benzamide
|
||||
| Synonyms |
CHEMBL245948
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H24N6O2
|
||||
| Canonical SMILES |
CNc1ncnc(n1)c2cccnc2Oc3cccc(NC(=O)c4cccc(c4)C(C)C)c3
|
||||
| InChI |
InChI=1S/C25H24N6O2/c1-16(2)17-7-4-8-18(13-17)23(32)30-19-9-5-10-20(14-19)33-24-21(11-6-12-27-24)22-28-15-29-25(26-3)31-22/h4-16H,1-3H3,(H,30,32)(H,26,28,29,31)
|
||||
| InChIKey |
ROJPTCGXRHNIRD-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.